Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Lymphoma 12Central Nervous System Neoplasms 10Brain Neoplasms 9Astrocytoma 9Oligodendroglioma 8Gliosarcoma 8Glioblastoma 8Lymphoma, Large B-Cell, Diffuse 4Glioma 4Ependymoma 4Multiple Myeloma 3Lymphoma, Follicular 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Neoplasms, Plasma Cell 2Neoplasm Metastasis 2Medulloblastoma 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Hodgkin Disease 2Sezary Syndrome 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive 1Mycosis Fungoides 1Melanoma 1Lymphoma, Large-Cell, Anaplastic 1Leukemia 1Head and Neck Neoplasms 1

Interventions

Temozolomide 3Vincristine 2Irinotecan 2Cyclophosphamide 2veliparib 1gallium Ga 68 dotatate 1entinostat 1carboxyamido-triazole 1adavosertib 1Verteporfin 1Surgical Procedures, Operative 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Paclitaxel 1Methotrexate 1Magnetic Resonance Spectroscopy 1Lenalidomide 1Immunoglobulin G 1Filgrastim 1Etoposide 1Erlotinib Hydrochloride 1Doxorubicin 1Disulfides 1Congresses as Topic 1Cisplatin 1Chemotherapy, Adjuvant 1Carmustine 1Bevacizumab 12-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Neuroectodermal Tumors, Primitive × Carmustine × Clear all
NCT00004028 2009-02-09

Carmustine in Treating Patients With Recurrent Malignant Glioma

National Cancer Institute (NCI)

Phase 1 Completed
CNSSarcoma

Astrocytoma, Brain Neoplasms, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡